生物制药迎来生物加工4.0时代

Q4 Biochemistry, Genetics and Molecular Biology

Genetic Engineering & Biotechnology News Pub Date : 2023-10-01 DOI:10.1089/gen.43.10.21

Gareth John Macdonald

{"title":"生物制药迎来生物加工4.0时代","authors":"Gareth John Macdonald","doi":"10.1089/gen.43.10.21","DOIUrl":null,"url":null,"abstract":"Genetic Engineering & Biotechnology NewsVol. 43, No. 10 BioprocessingBiopharma Taps Bioprocessing 4.0 Benefits Start FlowingExperts from Cytiva, Lonza, and Pfizer describe how biopharma is embracing data-driven and software-defined bioprocessing systemsGareth John MacdonaldGareth John MacdonaldSearch for more papers by this authorPublished Online:13 Oct 2023https://doi.org/10.1089/gen.43.10.21AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 43Issue 10Oct 2023 Information© 2023 by GEN PublishingTo cite this article:Gareth John Macdonald.Biopharma Taps Bioprocessing 4.0 Benefits Start Flowing.Genetic Engineering & Biotechnology News.Oct 2023.54-56, 58.http://doi.org/10.1089/gen.43.10.21Published in Volume: 43 Issue 10: October 13, 2023PDF download","PeriodicalId":50425,"journal":{"name":"Genetic Engineering & Biotechnology News","volume":"111 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Biopharma Taps Bioprocessing 4.0 Benefits Start Flowing\",\"authors\":\"Gareth John Macdonald\",\"doi\":\"10.1089/gen.43.10.21\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Genetic Engineering & Biotechnology NewsVol. 43, No. 10 BioprocessingBiopharma Taps Bioprocessing 4.0 Benefits Start FlowingExperts from Cytiva, Lonza, and Pfizer describe how biopharma is embracing data-driven and software-defined bioprocessing systemsGareth John MacdonaldGareth John MacdonaldSearch for more papers by this authorPublished Online:13 Oct 2023https://doi.org/10.1089/gen.43.10.21AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 43Issue 10Oct 2023 Information© 2023 by GEN PublishingTo cite this article:Gareth John Macdonald.Biopharma Taps Bioprocessing 4.0 Benefits Start Flowing.Genetic Engineering & Biotechnology News.Oct 2023.54-56, 58.http://doi.org/10.1089/gen.43.10.21Published in Volume: 43 Issue 10: October 13, 2023PDF download\",\"PeriodicalId\":50425,\"journal\":{\"name\":\"Genetic Engineering & Biotechnology News\",\"volume\":\"111 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Genetic Engineering & Biotechnology News\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1089/gen.43.10.21\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Biochemistry, Genetics and Molecular Biology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Genetic Engineering & Biotechnology News","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/gen.43.10.21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}

引用次数: 0

摘要

基因工程与生物技术新闻卷。43、No. 10生物加工生物制药利用生物加工4.0效益开始流动Cytiva, Lonza，和辉瑞公司描述了生物制药如何拥抱数据驱动和软件定义的生物处理系统加雷斯·约翰·麦克唐纳加雷斯·约翰·麦克唐纳搜索本文作者的更多论文发表在线:2023年10月13日https://doi.org/10.1089/gen.43.10.21AboutSectionsView文章查看全文pdf /EPUB权限和引文spermissions下载引文strack引文添加到收藏回到出版物共享分享在facebook上推特链接在redditemail查看文章figuresreferencesrelateddetails卷信息来源:GEN publishing©2023本文作者:Gareth John Macdonald。生物制药迎来生物加工4.0时代。基因工程与生物技术新闻。2023.54- 56,58 .http://doi.org/10.1089/gen.43.10.21Published in Volume: 43 Issue 10: October 13, 2023PDF下载

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Biopharma Taps Bioprocessing 4.0 Benefits Start Flowing

Genetic Engineering & Biotechnology NewsVol. 43, No. 10 BioprocessingBiopharma Taps Bioprocessing 4.0 Benefits Start FlowingExperts from Cytiva, Lonza, and Pfizer describe how biopharma is embracing data-driven and software-defined bioprocessing systemsGareth John MacdonaldGareth John MacdonaldSearch for more papers by this authorPublished Online:13 Oct 2023https://doi.org/10.1089/gen.43.10.21AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 43Issue 10Oct 2023 Information© 2023 by GEN PublishingTo cite this article:Gareth John Macdonald.Biopharma Taps Bioprocessing 4.0 Benefits Start Flowing.Genetic Engineering & Biotechnology News.Oct 2023.54-56, 58.http://doi.org/10.1089/gen.43.10.21Published in Volume: 43 Issue 10: October 13, 2023PDF download

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Genetic Engineering & Biotechnology News 工程技术-生物工程与应用微生物

CiteScore

0.20

自引率

0.00%

发文量

210

审稿时长

3-6 weeks

期刊介绍： Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Launched in 1980, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new technologies and applications, investment growth, and career opportunities. With nearly 40 years of publishing experience, GEN maintains unrivaled integrity, influence, and expertise that plays a pivotal role in driving the productivity and growth of the industry. Through its cornerstone Magazine, high-frequency newsletters, and dynamic suite of multimedia resources, GEN is the 360-degree resource that researchers and executives depend on for information that is pivotal for their organization’s success. GEN’s breadth of editorial coverage is unrivaled in the industry, providing exclusive coverage of the entire bioproduct lifecycle across five key pillars: Drug Discovery, Bioprocessing, OMICS, Translational Medicine, and Gene Editing.